GlassScriptPhysician profile
Darin T Clark
NPI 1568439537
$830.91
in general payments reported to CMS, 2019-2025
14 companies · $129 in 2025
The $129 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $247 · 2022: $276 · 2023: $108 · 2024: $71.75 · 2025: $129.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $308.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $308.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $150.93 | 2022-2025 | |
| Novo Nordisk INC | $149.83 | 2021-2025 | Rybelsus, Ozempic, Wegovy |
| Abbvie INC. | $117.88 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $99.33 | 2021-2022 | |
| Amgen INC. | $76.71 | 2021-2025 | Evenity |
| Janssen Pharmaceuticals, INC | $43.19 | 2021 | |
| Glaxosmithkline, LLC. | $38.04 | 2021-2023 | Arexvy |
| Hologic Sales and Service, LLC | $36.39 | 2022-2025 | Aptima |
| E.R. Squibb & Sons, L.L.C. | $32.35 | 2022 | |
| Axsome Therapeutics, INC. | $23.20 | 2024 | Sunosi |
| Cranial Technologies, INC | $20.61 | 2025 | Doc Band |
| Takeda Pharmaceuticals U.S.A., INC. | $17.12 | 2021 | |
| Rgh Enterprises LLC | $12.86 | 2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $12.47 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Darin Clark listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.